This article and associated images are based on a poster originally authored by Marina Fedorova and Ian Hiles and presented at ELRIG Drug Discovery 2024 in affiliation with GSK. This poster is being ...

Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...

Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

Proteins are made of chains of amino acids, and a basic tenet of biology is that the sequence of amino acids determines how a protein folds into a 3D shape which, in turn, dictates the protein’s ...

“Imagine a future in which you can design enzymes - natures catalysts – for your specific application at the push of button”, says Gustav Oberdorfer who headed the ERC Starting Grant project ...

What if we could design proteins that mimic nature’s signaling mechanisms but with enhanced precision and stability? A recent study published in Nature Chemistry ventured into the groundbreaking realm ...

Making biofuels is messy, inefficient and expensive. Vast quantities of crops such as maize and soyabeans must be grown, harvested and processed before their energy, accumulated slowly through natural ...

CAMBRIDGE, England & BOSTON & VILLIGEN, Switzerland--(BUSINESS WIRE)--Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based ...

Partnership will deliver AI-guided end-to-end workflow to access challenging membrane protein targets To de-risk and shorten path to critical structural and biophysical insights that inform ...